GLP-1 Insurance Denial? Here's Exactly How to Win Your Appeal

Getting denied for GLP-1 coverage is frustrating — but it's not the end of the road. Research shows that 30–50% of well-documented GLP-1 appeals succeed. Most initial denials are automated or based on incomplete information, not a final clinical judgment.

This guide walks you through exactly how to build and win your appeal.

Why Denials Happen

The most common reasons for GLP-1 denial aren't that you don't qualify — they're documentation gaps:

• Missing BMI documentation — Your doctor submitted the request but forgot to include your BMI or included only one measurement instead of two
• No comorbidity evidence — For BMI 27–29.9, you need documented weight-related conditions with lab results
• No failed lifestyle intervention — Many plans require 3–6 months of documented diet and exercise attempts
• Wrong diagnosis code — The same drug prescribed for obesity vs. diabetes is covered differently. Ozempic for T2D is covered by ~85% of plans; Wegovy for obesity by only ~45%
• Step therapy not completed — Some insurers require trying cheaper alternatives first (metformin, phentermine)

The Appeal Process: Step by Step

Step 1: Request the Written Denial

Call your insurer and request the denial letter with specific denial reasons and the clinical criteria they applied. You need to know exactly what was missing to fix it.

Step 2: Gather Your Documentation

Build your appeal packet:

• Two BMI measurements from different dates (showing consistent eligibility)
• Lab results documenting comorbidities (A1C for prediabetes, lipid panel, blood pressure records)
• 3–6 months of documented weight-loss attempts (nutritionist visits, gym records, food journals)
• A Letter of Medical Necessity from your prescribing doctor

Step 3: Write the Letter of Medical Necessity

This letter is the single most important document. It should come from your doctor and include:

• Your clinical diagnosis with ICD-10 codes (E66.01 for morbid obesity, E66.09 for other obesity, E11.xx for T2D)
• Why GLP-1 therapy is medically necessary for your specific situation
• Why alternatives (lifestyle alone, other medications) have been insufficient
• Clinical evidence supporting GLP-1 use for your condition

Step 4: Submit and Follow Up

Submit your appeal within the timeline specified in your denial letter (typically 30–180 days). Follow up weekly. If the internal appeal fails, you have the right to an external review by an independent third party.

The Diagnosis Code Strategy

Insurance coverage for semaglutide depends heavily on which brand is prescribed and what it's prescribed for. If you have type 2 diabetes, your doctor may be able to prescribe Ozempic (covered by ~85% of plans) rather than Wegovy — same active ingredient, different indication and coverage rate.

If your doctor determines GLP-1 therapy is appropriate for both your diabetes and weight management, the diabetes indication may provide a clearer path to coverage.

If the Appeal Fails

You still have options. Cash-pay compounded semaglutide through licensed telehealth platforms costs $130–$200/mo — a fraction of brand-name retail prices.